AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
9.57
+0.17 (1.81%)
Sep 11, 2024, 4:00 PM EDT - Market closed
AVITA Medical Market Cap
AVITA Medical has a market cap or net worth of $250.89 million as of September 11, 2024. Its market cap has decreased by -38.22% in one year.
Market Cap
250.89M
Enterprise Value
241.92M
1-Year Change
-38.22%
Ranking
Category
Stock Price
$9.57
Market Cap Chart
Since October 2, 2019, AVITA Medical's market cap has decreased from $666.70M to $250.89M, a decrease of -62.37%. That is a compound annual growth rate of -17.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2024 | 244.30M | -30.32% |
| Dec 29, 2023 | 350.60M | 112.23% |
| Dec 30, 2022 | 165.20M | -44.68% |
| Dec 31, 2021 | 298.60M | -25.68% |
| Dec 31, 2020 | 401.80M | -52.81% |
| Dec 31, 2019 | 851.40M | 27.70% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amarin Corporation | 246.13M |
| Acrivon Therapeutics | 244.68M |
| SOPHiA GENETICS | 244.31M |
| Sera Prognostics | 243.59M |
| Abeona Therapeutics | 243.43M |
| Rigel Pharmaceuticals | 236.48M |
| Nanobiotix | 233.44M |
| Utah Medical Products | 229.94M |